Novel phospholipid-based drug formulation retards the 6-hydroxydopamine-induced degeneration of rat nigral dopaminergic neurons.
- A. Fisher (Speaker)
- D. M. Harris (Speaker)
- A. J. Harkin (Speaker)
- Anthony E. Bolton (Speaker)
- Sullivan, A. (Speaker)
- Nolan, Y. (Speaker)
Activity: Talk or presentation › Invited talk